Skip to Main Content
Qurgen Qurgen
Menu Button

June-July 2025

Brand Icon
During June – July of 2025, Qurgen had successfully manufactured two lots of GMP-manufactured SON-DP anti-cancer drugs that met FDA/CDE protein drug quality standard. Both lots of SON-DP will be used in the US and China Phase I clinical trials.

Recent important events

Mar. 2026
Qurgen announced that a late-stage of ocular melanoma patient from the ongoing Qurgen clinical trial...
Learn More
Jan. 13, 2026
Dr. Chai Yan officially Joined Qurgen/Fuent (The Qurgen’s China subsidiary) as Senior Vice President of...
Learn More